Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Respiratory tract illness with unknown etiology
- Unidentified virus cytopathic effect in cell cultures
- Newly discovered paramyxovirus: EM
- Newly discovered paramyxovirus: diagnosis
- Virus identification: RAP-PCR
- Virus identification: nucleic acid purification
- Virus identification: example of RAP-PCR
- hMPV genome organization
- hMPV family tree
- hMPV seroprevalence
- hMPV genetic diversity
- hMPV antigenic diversity
- hMPV disease 1981-2001 in the Netherlands
- hMPV disease 2000-2002 in the Netherlands
- hMPV clinical 2000-2002 patient populations
- hMPV clinical 2000-2002 children
- hMPV clinical 2000-2002 demography
- hMPV clinical 2000-2002 symptoms
- hMPV clinical 2000-2002 intervention
- hMPV seasonality
- hMPV age distribution
- hMPV clinical 200-2002 prevalence
- Koch's postulates
- hMPV in cynomolgus macaques
- Rivers' modified Koch's postulates
- hMPV susceptible populations
- hMPV 20-year retrospective study
- hMPV risk groups
- Unidentifiable human coronavirus
- Human coronavirus: CPE in Vero cells
- Human coronavirus negative contrast EM
- Coronaviruses: group classification
- Human coronavirus sequence analyses
- HCoV-NL genome organisation
- HCoV-NL amino acid sequence comparison
- HCoV-NL phylogeny
- HCoV-NL prevalence in hospitalized individuals
- Patients with HCoV-NL-associated RTI
- HCoV-NL63 discoveries
- HCoV-NL63 clinical
- HCoV-HKU1 discovery
- HCoV-HKU1 phylogeny
- HCoV-HKU1 impact
- Bat coronaviruses
- Newly discovered human parvovirus: HBoV
- HBoV genetic screening
- HBoV genome organization and phylogeny
- HBoV clinical
- Emerging respiratory viruses: conclusions
Topics Covered
- Respiratory viruses
- Respiratory disease
- Virus discovery
- Koch's postulates
- Human metapneumovirus
- Human coronavirus NL63
- Human coronavirus HKU
- Human bocavirus
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Fouchier, R. (2017, May 2). Emerging respiratory viruses - discoveries between 2001 and 2005 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/WBMH2803.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Ron Fouchier has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Emerging respiratory viruses - discoveries between 2001 and 2005
A selection of talks on Microbiology
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name is Ron Fouchier,
Virologist at Erasmus Medical Centre in Rotterdam.
In this presentation, I will discuss
the discovery and characterization of four viral pathogens that
are associated with respiratory illnesses in
humans and that have been described since 2001.
The pathogens are first a paramyxovirus named
Human metapneumovirus, two human coronaviruses,
NL63 and HKU1, and a parvovirus named Human bocavirus.
0:29
It is well known that a wide range of
pathogens can cause respiratory tract illnesses in humans.
Viruses are the most frequently detected causative agents,
in particular, 40 acute respiratory tract illnesses.
As an example, this slide shows the result of diagnostic tests for 540 patients
with respiratory problems visiting
their general practitioner about 10 years ago in the Netherlands.
Several notorious pathogens were circulating this winter season with enteroviruses,
respiratory syncytial virus, influenza A and B virus,
and rhinoviruses as the most frequently detected viral pathogens.
The reason why I put this slide up is not so much the positive diagnostic results,
which can vary considerably between studies,
but to point out that in a significant proportion of the patients,
in this case 36 percent,
no known pathogen could be detected.
This proportion of respiratory tract illnesses with unknown etiology is highly variable,
for instance, for different patient populations, locations and timing.
But in most studies like this one,
an etiological agent cannot be identified in
a large proportion of patients under investigation.
I will discuss some of the viral pathogens that have been discovered in
the past six or seven years by research groups attempting
to reduce this proportion of illnesses with unknown etiology.
In 2001, a study by the Van der Hoek and others in the Netherlands described